CZQ-23462-50654
4 vaccinations
8 coded responses
17 check-ins
7 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 981 / WA
- Registered
- 2021-05-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-19
Dose 1 — Pfizer-BioNTech
-
2021-05-04
Registered in v-safe
- 2021-05-04
-
2021-05-10
Dose 2 — Pfizer-BioNTech
-
2021-05-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessAdult check-in
-
2021-05-12
Survey response — days 1–6 daily, dose 2MedDRA: Fluid retention — Feeling: Good · Site: Pain · Joint pains, Fatigue or tirednessFree text: Have fluid retention especially in feet, ankles and hands. This started the day I received the second dose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-13
Survey response — days 1–6 daily, dose 2MedDRA: Fluid retention — Feeling: Good · Headache, Joint painsFree text: Fluid retention in ankles, feet and handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-14
Survey response — days 1–6 daily, dose 2MedDRA: Fluid retention — Feeling: GoodFree text: Fluid retention in ankles and feetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-15
Survey response — days 1–6 daily, dose 2MedDRA: Fluid retention — Feeling: GoodFree text: Some fluid retention in ankles and feet, but it has improved today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-16
Survey response — days 1–6 daily, dose 2MedDRA: Fluid retention, Oedema peripheral — Feeling: Good · Joint painsFree text: Fluid retention in feet and ankles but improved from yesterdayMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-17
Survey response — day 7, dose 2MedDRA: Fluid retention — Feeling: Good · Joint painsFree text: Fluid retention seems to have resolved today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-25
- 2021-06-01
- 2021-06-07
- 2021-06-14
- 2021-06-21
- 2021-08-09
-
2021-11-08
Survey response — 6 months, dose 2MedDRA: Eczema, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: I have developed eczema in a couple of places and have not had this before to this degree. · Healthcare visit (other): In person visit with my primary care practitionerMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-12-10
Dose 3 — Pfizer-BioNTech
- 2022-05-10
-
2022-10-05
Dose 4 — Pfizer-BioNTech
-
2023-04-06
Survey response — 6 months, dose 4MedDRA: Heavy menstrual bleeding, Menstruation irregular — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-04-06
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-04-06
-
2023-04-06
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-19 | Pfizer-BioNTech | |
| 2 | 2021-05-10 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
| 4 | 2022-10-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Have fluid retention especially in feet, ankles and hands. This started the day I received the second dose.
Systemic reaction (other): Fluid retention in ankles, feet and hands
Systemic reaction (other): Fluid retention in ankles and feet
Systemic reaction (other): Some fluid retention in ankles and feet, but it has improved today.
Systemic reaction (other): Fluid retention in feet and ankles but improved from yesterday
Release 8 — day 7, dose 2
Systemic reaction (other): Fluid retention seems to have resolved today.
Release 10 — 6 months, dose 2
Symptoms: I have developed eczema in a couple of places and have not had this before to this degree.
Healthcare visit (other): In person visit with my primary care practitioner
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Eczema | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Menstruation irregular | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SRO | Fluid retention | ✓ | ✓ | ✓ |
| SRO | Oedema peripheral | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release